These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 30507951

  • 21. Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge.
    Mezhenskaya D, Isakova-Sivak I, Matyushenko V, Donina S, Rekstin A, Sivak K, Yakovlev K, Katelnikova A, Kryshen K, Makarov V, Rudenko L.
    Viruses; 2021 Jun 30; 13(7):. PubMed ID: 34209093
    [Abstract] [Full Text] [Related]

  • 22. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
    Li J, Arévalo MT, Chen Y, Chen S, Zeng M.
    Int J Infect Dis; 2014 Oct 30; 27():37-43. PubMed ID: 25172265
    [Abstract] [Full Text] [Related]

  • 23. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF, Zhang AJ, To KK, Chan JF, Li P, Wong TL, Zhang R, Chan TC, Chan BC, Wai HH, Chan LW, Fong HP, Hui RK, Kong KL, Leung AC, Ngan AH, Tsang LW, Yeung AP, Yiu GC, Yung W, Lau JY, Chen H, Chan KH, Yuen KY.
    Lancet Infect Dis; 2016 Feb 30; 16(2):209-18. PubMed ID: 26559482
    [Abstract] [Full Text] [Related]

  • 24. Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Moser MJ, Hatta Y, Gabaglia C, Sanchez A, Dias P, Sarawar S, Kawaoka Y, Hatta M, Neumann G, Bilsel P.
    Vaccine; 2019 Jul 26; 37(32):4533-4542. PubMed ID: 31280945
    [Abstract] [Full Text] [Related]

  • 25. Localized mucosal response to intranasal live attenuated influenza vaccine in adults.
    Barría MI, Garrido JL, Stein C, Scher E, Ge Y, Engel SM, Kraus TA, Banach D, Moran TM.
    J Infect Dis; 2013 Jan 01; 207(1):115-24. PubMed ID: 23087433
    [Abstract] [Full Text] [Related]

  • 26. Immunogenicity and safety of an egg-based inactivated quadrivalent influenza vaccine (GC3110A) versus two inactivated trivalent influenza vaccines with alternate B strains: A phase Ⅲ randomized clinical trial in adults.
    Song JY, Lee J, Woo HJ, Wie SH, Lee JS, Kim SW, Kim TH, Jung SI, Noh JY, Choi WS, Cheong HJ, Kim WJ.
    Hum Vaccin Immunother; 2019 Jan 01; 15(3):710-716. PubMed ID: 30396317
    [Abstract] [Full Text] [Related]

  • 27. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.
    Tsurudome Y, Kimachi K, Okada Y, Matsuura K, Ooyama Y, Ibaragi K, Kino Y, Ueda K.
    Microbiol Immunol; 2015 Oct 01; 59(10):597-604. PubMed ID: 26272602
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
    Block SL, Falloon J, Hirschfield JA, Krilov LR, Dubovsky F, Yi T, Belshe RB.
    Pediatr Infect Dis J; 2012 Jul 01; 31(7):745-51. PubMed ID: 22466322
    [Abstract] [Full Text] [Related]

  • 29. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
    Bragstad K, Martel CJ, Thomsen JS, Jensen KL, Nielsen LP, Aasted B, Fomsgaard A.
    Influenza Other Respir Viruses; 2011 Jan 01; 5(1):13-23. PubMed ID: 21138536
    [Abstract] [Full Text] [Related]

  • 30. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
    Smith A, Rodriguez L, El Ghouayel M, Nogales A, Chamberlain JM, Sortino K, Reilly E, Feng C, Topham DJ, Martínez-Sobrido L, Dewhurst S.
    J Virol; 2020 Jan 31; 94(4):. PubMed ID: 31748399
    [Abstract] [Full Text] [Related]

  • 31. The need for quadrivalent vaccine against seasonal influenza.
    Belshe RB.
    Vaccine; 2010 Sep 07; 28 Suppl 4():D45-53. PubMed ID: 20713260
    [Abstract] [Full Text] [Related]

  • 32. Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil.
    Zerbini CA, Ribeiro Dos Santos R, Jose Nunes M, Soni J, Li P, Jain VK, Ofori-Anyinam O.
    Braz J Infect Dis; 2017 Sep 07; 21(1):63-70. PubMed ID: 27912069
    [Abstract] [Full Text] [Related]

  • 33. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    Mohn KG, Brokstad KA, Islam S, Oftung F, Tøndel C, Aarstad HJ, Cox RJ.
    J Infect Dis; 2020 Apr 07; 221(9):1528-1537. PubMed ID: 32255493
    [Abstract] [Full Text] [Related]

  • 34. Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
    Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P.
    Vaccine; 2018 Aug 09; 36(33):5097-5103. PubMed ID: 30007825
    [Abstract] [Full Text] [Related]

  • 35. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
    Loebermann M, Voss U, Meyer S, Bosse D, Fritzsche C, Klammt S, Frimmel S, Riebold D, Reisinger EC.
    PLoS One; 2013 Aug 09; 8(8):e70866. PubMed ID: 23976960
    [Abstract] [Full Text] [Related]

  • 36. Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.
    Essink B, Fierro C, Rosen J, Figueroa AL, Zhang B, Verhoeven C, Edelman J, Smolenov I.
    Vaccine; 2020 Jan 10; 38(2):242-250. PubMed ID: 31635976
    [Abstract] [Full Text] [Related]

  • 37. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM.
    MMWR Recomm Rep; 2022 Aug 26; 71(1):1-28. PubMed ID: 36006864
    [Abstract] [Full Text] [Related]

  • 38. Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.
    Cherukuri A, Servat E, Woo J.
    Vaccine; 2012 Jan 05; 30(2):237-46. PubMed ID: 22080173
    [Abstract] [Full Text] [Related]

  • 39. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM, Yi T, Ambrose CS.
    Vaccine; 2011 Jun 10; 29(26):4322-7. PubMed ID: 21513761
    [Abstract] [Full Text] [Related]

  • 40. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Puig-Barberà J, Guglieri-López B, Tortajada-Girbés M, López-Labrador FX, Carballido-Fernández M, Mollar-Maseres J, Schwarz-Chavarri G, Baselga-Moreno V, Mira-Iglesias A, Díez-Domingo J, Valencia Hospital Network for the Study of Influenza, Respiratory Viruses Disease.
    Vaccine; 2017 Dec 19; 35(52):7331-7338. PubMed ID: 29128380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.